Any feedback?
Literature summary for 5.1.99.4 extracted from
- Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens (2009), Am. J. Clin. Pathol., 132; 211-20, 307.
Application
| Application | Comment | Organism |
|---|---|---|
| diagnostics | cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| prostate adenocarcinoma cell | - |
Homo sapiens | - |
| prostate gland | - |
Homo sapiens | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| alpha-methylacyl-CoA racemase | - |
Homo sapiens |
| AMACR | - |
Homo sapiens |
Expression
| Organism | Comment | Expression |
|---|---|---|
| Homo sapiens | AMACR is negative in postatrophic hyperplasia, mucinous metaplasia, and urothelial metaplasia | down |
| Homo sapiens | AMACR is overexpressed in prostate cancer | up |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
